With regard to the cost paid by the government for prescribed medical marijuana and other prescribed pharmaceuticals for use by Members of the Canadian Armed Forces and Veterans of the Canadian Armed Forces, that are administered by Veterans Affairs Canada: (a) what has been the total cost, broken down by year, from 2007 to present, prepared in chart format, for (i) medical marijuana, (ii) Diazepam, (iii) Clonazepam, (iv) Trazodone, (v) Zopiclone, (vi) Wellbutrin, (vii) Effexor, (viii) Celexa, (ix) Seroquel, (x) Ambien, (xi) Remeron, (xii) Nabilone, (xiii) Valium, (xiv) Prazosin, (xv) Oxycodone, (xvi) Demerol, (xvii) Dilaudid, (xviii) Fentanyl, (xix) Mirtazapine, (xx) Gabapentin, (xxi) Baclofen, (xxii) Propranolol, (xxiii) Targin, (xxiv) Pantoprazole, (xxv) Nortriptyline, (xxvi) Ketoconazole, (xxvii) all other prescribed pharmaceuticals, including opioids and other pain relief medications; and (b) what evidence, reports, scientific studies or other types of studies have been used as a frame of reference to evaluate the use, be it prescription use, non-use or non-prescription use, of the pharmaceuticals identified in (a)?